• #974482
  • 43
  • Sanofi Pasteur #562-10

Quadracel™ DTaP and Polio Vaccine 4 to 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine Injection Single Dose Vial 0.5 mL

QUADRACEL, SDV 0.5ML (10/BX)

Features
  • Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis
  • A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a fourth or fifth dose in the inactivated poliovirus vaccination (IPV) series, in children who have received 4 doses of Pentacel and/or DAPTACEL vaccine
  • Each 0.5 mL dose is formulated to contain 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], and inactivated polioviruses [40 D-antigen units (DU) Type 1 (Mahoney), 8 DU Type 2 (MEF-1), 32 DU Type 3 (Saukett)]
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #974482
Manufacturer #562-10
BrandQuadracel™
ManufacturerSanofi Pasteur
Country of OriginCanada
ApplicationDTaP and Polio Vaccine
Container TypeSingle Dose Vial
Dosage FormInjection
Generic Drug NameDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
NDC Number49281-0562-10
Product DatingMcKesson Acceptable Dating: we will ship >= 180 days
Storage RequirementsRequires Refrigeration
Strength15 Lf - 5 Lf - 20 mcg
TypeIntramuscular
UNSPSC Code51202100
User4 to 6 Years of Age
Volume0.5 mL
Features
  • Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis
  • A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a fourth or fifth dose in the inactivated poliovirus vaccination (IPV) series, in children who have received 4 doses of Pentacel and/or DAPTACEL vaccine
  • Each 0.5 mL dose is formulated to contain 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], and inactivated polioviruses [40 D-antigen units (DU) Type 1 (Mahoney), 8 DU Type 2 (MEF-1), 32 DU Type 3 (Saukett)]